【亚盛医药-B(06855.HK)委任Marc E. Lippman, MD为独立非执行董事】亚盛医药-B(06855.HK)公布,已委任Marc E. Lippman, MD为公司额外独立非执行董事,自2025年1月2日起生效。

金融界
02 Jan
亚盛医药-B(06855.HK)公布,已委任Marc E. Lippman, MD为公司额外独立非执行董事,自2025年1月2日起生效。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10